Clinical trials are an important way to improve treatment for people with cancer. While most are continuing during the COVID-19 pandemic, the period of time that clinical trials are available and recruiting may change quickly. If you would like to get involved in a clinical trial, speak to your treatment team or the health service where the clinical trial is being undertaken, to confirm it is open and appropriate for you. For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm.

I-PACE : Phase 2 Study of Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (I-PACE)

Male or<br/>FemaleGender Male or

CompletedStatus Completed

Systemic<br/>Therapy TrialTypeSystemic
Therapy Trial

TwoPhase Two

18+Age Over 18

Skin<br/>CancersCancer LocationSkin

Systemic therapy | SkinCutaneous Squamous Cell Carcinoma (CSCC)

Trial Overview Read MoreRead more

This phase II study is evaluating how safe and effective a targeted therapy (imgatuzumab) is in people with advanced cutaneous squamous cell carcinoma.

This trial is treating patients with advanced cutaneous squamous cell carcinoma.

This is a systemic therapy trial.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have had certain treatments, surgical procedures or drugs.
  • You have previously been treated (or are currently being treated) on a clinical trial.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

Phase 2 Study of Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (I-PACE)

Commercial Sponsor

Pega-One S.A.S.


Eligible participants in this trial will receive Imgatuzumab as monotherapy. Imgatuzumab will be administered as an intravenous infusion on Day 1 and Day 8 of the first 21-day cycle, and on Day 1 of each subsequent 14-day cycle.

Not Recruiting Hospitals Read MoreRead more


PCCTU (Parkville Cancer Clinical Trials Unit) *
Monc C Co-Team Leads

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.